Published in Arch Bronconeumol on December 01, 1999
[2002: a good year for turning approach to COPD around]. Arch Bronconeumol (2002) 2.65
Predisposing factors to bacterial colonization in chronic obstructive pulmonary disease. Eur Respir J (1999) 2.44
Prevalence of COPD in Spain: impact of undiagnosed COPD on quality of life and daily life activities. Thorax (2009) 2.27
[Antimicrobial therapy in exacerbated chronic obstructive pulmonary disease]. Arch Bronconeumol (2002) 2.03
Cytokine profile in quadriceps muscles of patients with severe COPD. Thorax (2007) 1.94
[Costs of chronic obstructive pulmonary disease in Spain. Estimation from a population-based study]. Arch Bronconeumol (2004) 1.62
Interpretation of quality of life scores from the St George's Respiratory Questionnaire. Eur Respir J (2002) 1.48
Smoking characteristics: differences in attitudes and dependence between healthy smokers and smokers with COPD. Chest (2001) 1.44
[Lung resection surgery in patients with functional limits]. Arch Bronconeumol (1996) 1.38
[Use of antibiotics in exacerbated chronic obstructive pulmonary disease]. Aten Primaria (2001) 1.31
Effect of montelukast added to inhaled budesonide on control of mild to moderate asthma. Thorax (2003) 1.22
Hyperleptinaemia, respiratory drive and hypercapnic response in obese patients. Eur Respir J (2007) 1.16
Safety and tolerability of NVA237, a once-daily long-acting muscarinic antagonist, in COPD patients. Pulm Pharmacol Ther (2010) 1.15
Community-acquired pneumonia in chronic obstructive pulmonary disease: a Spanish multicenter study. Am J Respir Crit Care Med (1996) 1.14
[Smoking habits among sixth-year medical students in Spain]. Arch Bronconeumol (2004) 0.87
[Evaluation of the ambulatory blood pressure monitor SAVE 33 model 2]. Arch Mal Coeur Vaiss (1999) 0.85
[The EPI-SCAN survey to assess the prevalence of chronic obstructive pulmonary disease in Spanish 40-to-80-year-olds: protocol summary]. Arch Bronconeumol (2009) 0.83
[Respiratory symptoms and diagnosis of COPD in smokers of various types to tobacco. Results from the IBERPOC study]. Arch Bronconeumol (2002) 0.83
[Usefulness of computerized tomography in the study of pleural effusion with no presumed diagnosis]. Arch Bronconeumol (1997) 0.81
[Mediastinal liposarcoma. A report of 2 cases]. Arch Bronconeumol (1999) 0.80
[Prevalence of and attitudes towards smoking in a population over 40 years of age]. Arch Bronconeumol (2000) 0.79
Influence of three factors on the diagnostic effectiveness of transthoracic needle aspiration in pneumonia. Chest (1995) 0.79
[Asbestos: characteristics, properties, pathogenesis and sources of exposure]. An Sist Sanit Navar (2005) 0.78
[Second consensus statement on the use of antimicrobial drugs in chronic obstructive pulmonary disease exacerbations]. Rev Esp Quimioter (2002) 0.77
[Early discharge and home health care program for patients with exacerbated COPD and asthma]. Arch Bronconeumol (2001) 0.77
[A multicenter study of the breaking of the smoking habit with nicotine chewing gum in health personnel]. Med Clin (Barc) (1991) 0.77
[Transthoracic aspiration punction with ultrafine needle in high risk community acquired pneumonia]. Med Clin (Barc) (1993) 0.77
[Diagnosis of tuberculosis infection]. An Sist Sanit Navar (2007) 0.76
Ten years follow up in patients with chronic obstructive lung disease submitted to a programme of pulmonary rehabilitation. J R Soc Med (1978) 0.75
Tonsillectomy à chaud for quinsy: revisited. Eur Arch Otorhinolaryngol (2007) 0.75
Low-dose formoterol Turbuhaler (Oxis) b.i.d., a 3-month placebo-controlled comparison with terbutaline (q.i.d.). Respir Med (1998) 0.75
[The internal consistency and content validity of the Spanish version of the Asthma Autonomy Questionnaire]. Arch Bronconeumol (2000) 0.75
[The role of the new quinolones in the treatment and prevention of tuberculosis and other infections caused by mycobacterium]. Enferm Infecc Microbiol Clin (1999) 0.75
[Persistent hemoptysis secondary to extensive epithelioid angiosarcoma]. Arch Bronconeumol (2004) 0.75
[Spirometry: quality in the respiratory medicine clinics of a public health care area]. Arch Bronconeumol (2002) 0.75
[Accreditation requirements for educational programs in respiratory medicine]. Arch Bronconeumol (2003) 0.75
[Skin tumor as presentation form of lung actinomycosis]. Arch Bronconeumol (1997) 0.75
[Glycolytic metabolism during muscular excerise in chronic broncho-pulmonary disease without hypoxemia (author's transl)]. Bull Physiopathol Respir (Nancy) (1975) 0.75
[Clinical and etiological features of community-acquired pneumonia in the elderly]. Enferm Infecc Microbiol Clin (1994) 0.75
[Current use, methodology and evaluation of nonspecific bronchial provocation tests in our country]. Arch Bronconeumol (1995) 0.75
[Pneumonia in alcoholic patients: the clinical and etiological characteristics]. Arch Bronconeumol (1994) 0.75
[Pleural effusion associated with primary lymphedema: a rare combination. Apropos of a case]. Med Clin (Barc) (1990) 0.75
[Epidemiological study of chronic obstructive pulmonary disease in Spain (IBERPOC): recruitment and field work]. Arch Bronconeumol (1999) 0.75
[Community acquired pneumonia. Reliability of the criteria for deciding ambulatory treatment]. Arch Bronconeumol (1997) 0.75
[Dog bite and Pasteurella multocida pneumonia]. Med Clin (Barc) (1996) 0.75
[Second consensus report on the use of antimicrobial agents in exacerbations of chronic obstructive pulmonary disease]. Arch Bronconeumol (2003) 0.75
[Amoxicillin and ampicillin in the patient with chronic bronchitis. Comparative study : bacteriological, pharmacological and clinical]. Nouv Presse Med (1975) 0.75
[Use of antibiotics in the exacerbation of chronic obstructive pulmonary disease]. Rev Esp Quimioter (2001) 0.75
[Bronchoconstriction caused by pressurized aerosol]. Med Clin (Barc) (1987) 0.75
[Compliance with inhalation treatment of patients with chronic obstructive pulmonary disease]. Arch Bronconeumol (2000) 0.75
[Tuberculosis in cavum: a case report]. Arch Bronconeumol (2001) 0.75
[Double-blind clinical trial comparing 5 days of dirithromycin versus 7 days of diacetylmidecamycin in acute bronchitis and acute exacerbations of chronic bronchitis]. Enferm Infecc Microbiol Clin (1997) 0.75
[Information seeking and decision making in asthmatic patients]. Arch Bronconeumol (1999) 0.75
[Protected bacteriologic brushing in patients with severe copd]. Arch Bronconeumol (1997) 0.75
[Dyspnea, chest pain and respiratory insufficiency in a 68-year-old man]. Med Clin (Barc) (1989) 0.75
[Building related ilness]. An Sist Sanit Navar (2005) 0.75